Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2022 Earnings Call Transcript November 8, 2022
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.3.
Operator: Good day and welcome to the Inovio Third Quarter 2022 Results Conference Call. Please note that this event is being recorded. I would now like to turn the conference over to Thomas Hong. Please go ahead sir.
Thomas Hong: Thank you. Good afternoon. And thank you for joining the Inovio’s...
